ADVANCE, a study of 1,015 patients who underwent transcatheter aortic valve implantation (TAVI) using Medtronic’s CoreValve system, continued to show clinical benefits at one year. The results were presented May 21 at EuroPCR 2013 in Paris.
Patients with coronary heart disease (CHD) who received selective serotonin reuptake inhibitors (SSRIs) for six weeks had a lower rate of mental stress-induced myocardial ischemia compared with those who took placebos, according to results of the REMIT trial published May 22 in the Journal of the American Medical Association.
The federal government will reduce rates paid to physicians and hospitals treating patients with cardiovascular diseases and other serious illnesses in an effort to stem the tide in cost overruns in its Pre-Existing Condition Insurance Plan (PCIP).
It’s a toss-up: In a comparison of their relative cardiovascular risk, neither of two long-acting bronchodilators for chronic obstructive pulmonary disease appeared to be safer than the other.
Authors of a report released by the Institute of Medicine (IOM) on sodium intake by the American public failed to be persuaded that lowering daily consumption below 2,300 mg a day affected outcomes. The American Heart Association (AHA) countered the report missed the mark in its conclusions.
